WW domain interactions regulate the Hippo tumor suppressor pathway
暂无分享,去创建一个
R. Aqeilan | Z. Salah | Z Salah | R I Aqeilan | R. Aqeilan
[1] Kevin J. Cheung,et al. Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP* , 2008, Journal of Biological Chemistry.
[2] Meng Yang,et al. Color-coded fluorescence imaging of tumor-host interactions , 2006, Nature Protocols.
[3] K. Hogue,et al. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ , 2010, Oncogene.
[4] Tony Pawson,et al. WW Domains Provide a Platform for the Assembly of Multiprotein Networks , 2005, Molecular and Cellular Biology.
[5] K. Guan,et al. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. , 2009, Cancer research.
[6] P. Bork,et al. Characterization of the Mammalian YAP (Yes-associated Protein) Gene and Its Role in Defining a Novel Protein Module, the WW Domain (*) , 1995, The Journal of Biological Chemistry.
[7] S. K. Zaidi,et al. Tyrosine phosphorylation controls Runx2‐mediated subnuclear targeting of YAP to repress transcription , 2004, The EMBO journal.
[8] Jeannie T. Lee,et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.
[9] M. Sudol,et al. Structure and function of the WW domain. , 1996, Progress in biophysics and molecular biology.
[10] K. Takamune,et al. A family with Liddle's syndrome caused by a new missense mutation in the beta subunit of the epithelial sodium channel. , 1998, The Journal of clinical endocrinology and metabolism.
[11] M. Ji,et al. KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases* , 2011, The Journal of Biological Chemistry.
[12] R. Aqeilan,et al. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. , 2011, Cancer research.
[13] Sho Fujisawa,et al. Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways , 2009, Cell.
[14] Scott A. Peterson,et al. Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.
[15] Jianmin Zhang,et al. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. , 2008, Cancer research.
[16] K. Irvine,et al. Processing and phosphorylation of the Fat receptor , 2009, Proceedings of the National Academy of Sciences.
[17] R. Ishima,et al. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. , 2011, Biochemistry.
[18] K. Guan,et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. , 2011, Genes & development.
[19] Juan Huang,et al. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded , 2010, Proceedings of the National Academy of Sciences.
[20] P. Schmieder,et al. WW domain sequence activity relationships identified using ligand recognition propensities of 42 WW domains , 2003, Protein science : a publication of the Protein Society.
[21] Zhengyu Zha,et al. TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway , 2008, Molecular and Cellular Biology.
[22] K. Harvey,et al. Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador–Warts–Hippo pathway , 2011, Cell Death and Differentiation.
[23] G. Feldmann,et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.
[24] Y. Xiong,et al. PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ* , 2010, The Journal of Biological Chemistry.
[25] K. Harvey,et al. Upstream Regulation of the Hippo Size Control Pathway , 2010, Current Biology.
[26] J. Wrana,et al. Phosphorylation of the Tumor Suppressor Fat Is Regulated by Its Ligand Dachsous and the Kinase Discs Overgrown , 2009, Current Biology.
[27] King Ching Hoa,et al. Correction for Ho et al., Itch E3 ubiquitin ligase regulates large tumor suppressor 1 tumor-suppressor stability , 2011, Proceedings of the National Academy of Sciences.
[28] N. Navin,et al. WW Domain-containing Protein YAP Associates with ErbB-4 and Acts as a Co-transcriptional Activator for the Carboxyl-terminal Fragment of ErbB-4 That Translocates to the Nucleus* , 2003, Journal of Biological Chemistry.
[29] T. Hunter,et al. NeW Wrinkles for an Old Domain , 2000, Cell.
[30] M. Saraste,et al. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide , 1996, Nature.
[31] D. Green,et al. The ubiquitin–protein ligase Itch regulates p73 stability , 2005, The EMBO journal.
[32] R. M. Simpson,et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression , 2010, Proceedings of the National Academy of Sciences.
[33] D. Haber,et al. salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines , 2002, Cell.
[34] M. Sudol,et al. Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)* , 2008, Journal of Biological Chemistry.
[35] M. MacDonald,et al. Huntingtin interacts with a family of WW domain proteins. , 1998, Human molecular genetics.
[36] K. Harvey,et al. The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network , 2007, Nature Reviews Cancer.
[37] K. Vousden,et al. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. , 2010, Genes & development.
[38] Y. She,et al. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability , 2011, Proceedings of the National Academy of Sciences.
[39] L. Schild,et al. A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Aqeilan,et al. WW domain-containing proteins: retrospectives and the future. , 2012, Frontiers in bioscience.
[41] Xin Huang,et al. Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan , 2000, Nature Structural Biology.
[42] Meng Yang,et al. Whole-body imaging with fluorescent proteins , 2006, Nature Protocols.
[43] I. Grundke‐Iqbal,et al. Site‐specific effects of tau phosphorylation on its microtubule assembly activity and self‐aggregation , 2007, The European journal of neuroscience.
[44] J. Campanelli,et al. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding. , 1999, Molecular cell biology research communications : MCBRC.
[45] K. Titani,et al. Hyperphosphorylation of Tau in PHF , 1995, Neurobiology of Aging.
[46] M. Sudol,et al. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[47] Marius Sudol,et al. WW and SH3 domains, two different scaffolds to recognize proline‐rich ligands , 2002, FEBS letters.
[48] Annalisa Pastore,et al. Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA Splicing* , 2010, The Journal of Biological Chemistry.
[49] Thomas Benjamin,et al. TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.
[50] Peter A. Lawrence,et al. Four-Jointed Modulates Growth and Planar Polarity by Reducing the Affinity of Dachsous for Fat , 2010, Current Biology.
[51] M. Sudol. Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway. , 2010, Genes & cancer.
[52] G. Halder,et al. The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila , 2010, Proceedings of the National Academy of Sciences.
[53] Y. Pekarsky,et al. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. , 2005, Cancer research.
[54] Li Li,et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.
[55] J. Woodgett,et al. When pathways collide: collaboration and connivance among signalling proteins in development , 2010, Nature Reviews Molecular Cell Biology.
[56] W. Deng,et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. , 2010, Developmental cell.
[57] Li Li,et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.
[58] P. Bork,et al. The WW domain: a signalling site in dystrophin? , 1994, Trends in biochemical sciences.
[59] R. Fehon,et al. Delineation of a Fat tumor suppressor pathway , 2006, Nature Genetics.
[60] M. MacDonald,et al. Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis. , 2000, Human molecular genetics.
[61] D. Pan,et al. The hippo signaling pathway in development and cancer. , 2010, Developmental cell.
[62] L. Castagnoli,et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. , 2001, The Journal of biological chemistry.
[63] Ingrid Poernbacher,et al. The WW domain protein Kibra acts upstream of Hippo in Drosophila. , 2010, Developmental cell.
[64] Frederic A. Fellouse,et al. The Hippo pathway regulates Wnt/beta-catenin signaling. , 2010, Developmental cell.
[65] K. Harvey,et al. Modularity in the Hippo signaling pathway. , 2010, Trends in biochemical sciences.
[66] E. Mandelkow,et al. Tau in Alzheimer's disease. , 1998, Trends in cell biology.
[67] Franca Fraternali,et al. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax , 2008, Nucleic acids research.
[68] I. Hariharan,et al. The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis , 2003, Cell.
[69] Robert M. Hoffman,et al. The multiple uses of fluorescent proteins to visualize cancer in vivo , 2005, Nature Reviews Cancer.
[70] Junjie Chen,et al. Angiomotin-like Proteins Associate with and Negatively Regulate YAP1* , 2010, The Journal of Biological Chemistry.
[71] A. Pobbati,et al. Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin* , 2011, The Journal of Biological Chemistry.
[72] B. Thompson,et al. Kibra Is a Regulator of the Salvador/Warts/Hippo Signaling Network , 2010, Developmental cell.
[73] Sharad Kumar,et al. The role of individual Nedd4–2 (KIAA0439) WW domains in binding and regulating epithelial sodium channels , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[74] Meng Yang,et al. Subcellular imaging in the live mouse , 2006, Nature Protocols.
[75] Giovanni Cesareni,et al. Modular protein domains , 2005 .
[76] R. Aqeilan,et al. WWOX: Its genomics, partners, and functions , 2009, Journal of cellular biochemistry.
[77] R. Aqeilan,et al. WWOX gene and gene product: tumor suppression through specific protein interactions. , 2010, Future oncology.